CDKN2A and gastric carcinoma: The 3’promoter hypermethylation is conserved to specific CpG sites associated with putative transcriptional start sites and is a late event in progression of gastric carcinoma as some p16-negative tumour areas were found to co-exist with p16-positive tumour regions in a study by Song et al [51].